Excelsior Biopharma Inc. (6496.TWO)

TWD 30.0

(0.0%)

Annual Balance Sheets

(In TWD)
Breakdown 2023 2022 2021 2020 2019
Total Assets 1.57 Billion 1.71 Billion 1.83 Billion 1.9 Billion -
Total Current Assets 984.09 Million 1.44 Billion 1.53 Billion 1.62 Billion -
Cash And Short Term Investments 589.91 Million 1.1 Billion 1.1 Billion 1.15 Billion -
Cash and Cash Equivalents 589.91 Million 895.27 Million 1.1 Billion 1.14 Billion -
Short Term Investments - 211.18 Million - 11.22 Million -
Net Receivables 162.72 Million 137.98 Million 214.51 Million 190.06 Million -
Inventory 217.28 Million 188.57 Million 204.6 Million 276.47 Million -
Other Current Assets 14.16 Million 10.09 Million 10.81 Million 4.49 Million -
Total Non-Current Assets 593.23 Million 271.85 Million 306.35 Million 277.29 Million 11.01 Million
Net PPE 473.19 Million 167.9 Million 188.08 Million 214.3 Million -
Good Will And Intangible Assets 42 Thousand 56 Thousand 70 Thousand 84 Thousand -
Good Will - - - - -
Intangible Assets 42 Thousand - - - -
Long-Term Investments 68.18 Million -141.74 Million - 12.32 Million -
Tax Assets 20.05 Million 20.15 Million 21.22 Million 18.32 Million -
Other Non Current Assets 31.76 Million 225.48 Million 96.97 Million 32.26 Million 11.01 Million
Other Assets - - - - -
Total Liabilities 472.87 Million 507.53 Million 608.89 Million 617.14 Million -
Total Current Liabilities 166.28 Million 458.63 Million 250.27 Million 248.65 Million -
Account Payables 22.23 Million 39.15 Million 88.94 Million 107.47 Million -
Tax Payables 4.9 Million 3.92 Million 4.1 Million 7.68 Million -
Short Term Debt 77.15 Million 332.79 Million 46.26 Million 34.01 Million -
Deferred Revenue 62.09 Million 80.27 Million 93.89 Million 86 Million -
Other Current Liabilities 4.8 Million 6.4 Million 21.16 Million 21.16 Million -
Total Non Current Liabilities 306.59 Million 48.89 Million 358.62 Million 368.49 Million -
Long-Term Debt 300.25 Million 43.04 Million 350.92 Million 361.36 Million -
Deferred Revenue Non Current - - - - -
Deferred Tax Liabilities Non Current - - - - -
Other Non Current Liabilities 6.34 Million 5.85 Million 7.7 Million 7.12 Million -
Other Liabilities - - - - -
Total Equity 1.1 Billion 1.2 Billion 1.23 Billion 1.28 Billion -
Stock Holders Equity 1.1 Billion 1.2 Billion 1.23 Billion 1.28 Billion -
Common Stock 477.91 Million 475.07 Million 466.67 Million 466.67 Million -
Retained Earnings 186.94 Million 278.19 Million 307.42 Million 370.77 Million -
Accumulated other comprehensive income 34.36 Million - - - -
Common Stock Equity 1.1 Billion 1.2 Billion 1.23 Billion 1.28 Billion -
Capital Lease Obligation 354.22 Million 53.79 Million 70.64 Million 83.43 Million -
Total Investments 68.18 Million 69.44 Million 74.13 Million 23.54 Million -
Total Debt 377.4 Million 375.83 Million 397.18 Million 395.38 Million -
Net Debt -212.51 Million -519.44 Million -705.57 Million -745.27 Million -

Balance Sheet Charts